📡 TrialPulse
Global clinical trial visibility
Trials Explorer
Filter the Neon trial store — status, phase, condition, country, sponsor class, results, and event history.
13,294 trials in store — showing first 100 · last ingest 20 Oct, 07:24 UTC: +0 new, 300 updated
| # | Trial | Status | Phase | Sponsor | Countries | Updated | |
|---|---|---|---|---|---|---|---|
| 1 | A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] NCT07111546 ↗ | RECRUITING | PHASE2 | Nanjing Leads Biolabs Co.,Ltd | China | 2026-10-19 | |
| 2 | Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients NCT04654689 ↗ | COMPLETED⚠ Results delaymedium +1073d | PHASE2 | Fundación Universidad Católica de Valencia San Vicente Mártir | Spain | 2026-10-19 | |
| 3 | Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females NCT07880444 ↗ | NOT YET RECRUITING | NA | San Diego State University | — | 2026-10-19 | |
| 4 | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica NCT07286214 ↗ | RECRUITING | PHASE4 | Sanofi | Austria, Belgium, Canada, Czechia, France, Germany, Greece, Netherlands, Spain, United States | 2026-10-19 | |
| 5 | A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners NCT05619185 ↗ | RECRUITING | NA | Stanford University | United States | 2026-10-19 | |
| 6 | Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent Asthma NCT03648450 ↗ | COMPLETEDResults | N/A | Connecticut Children's Medical Center | United States | 2026-10-19 | |
| 7 | Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial NCT06022965 ↗ | RECRUITING | NA | City of Hope Medical Center | United States | 2026-10-19 | |
| 8 | Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) NCT07296744 ↗ | RECRUITING | NA | Supira Medical | United States | 2026-10-19 | |
| 9 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes NCT07881458 ↗ | NOT YET RECRUITING | PHASE3 | Eli Lilly and Company | Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain, Taiwan, United States | 2026-10-19 | |
| 10 | Families Becoming Healthy Together NCT04027426 ↗ | COMPLETEDResults | NA | The University of Tennessee, Knoxville | United States | 2026-10-19 | |
| 11 | Reflexology Hand Massage After Cesarean Section NCT07880587 ↗ | RECRUITING | NA | Dokuz Eylul University | Turkey (Türkiye) | 2026-10-19 | |
| 12 | Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound NCT02343991 ↗ | COMPLETEDResults | NA | InSightec | Canada | 2026-10-19 | |
| 13 | The HIP Self-management Study NCT06297148 ↗ | ACTIVE NOT RECRUITING | NA | Oslo University Hospital | Norway | 2026-10-19 | |
| 14 | Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer NCT04014231 ↗ | COMPLETED | N/A | City of Hope Medical Center | United States | 2026-10-19 | |
| 15 | Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel NCT05751668 ↗ | ACTIVE NOT RECRUITING | PHASE2 | Alliance for Clinical Trials in Oncology | United States | 2026-10-19 | |
| 16 | Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse NCT06948084 ↗ | RECRUITING | PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 17 | Pain Phenotyping of Rheumatic Diseases - An Observational Study NCT07829497 ↗ | NOT YET RECRUITING | N/A | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | United States | 2026-10-19 | |
| 18 | Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy NCT06763328 ↗ | RECRUITING | PHASE3 | City of Hope Medical Center | United States | 2026-10-19 | |
| 19 | Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387 NCT07010159 ↗ | RECRUITING | PHASE2 / PHASE3 | Kiniksa Pharmaceuticals International, plc | Canada, France, Germany, Greece, Italy, Poland, Serbia, Spain, United Kingdom, United States | 2026-10-19 | |
| 20 | First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults NCT07848334 ↗ | ACTIVE NOT RECRUITING | PHASE1 | Otsuka Pharmaceutical Factory, Inc. | United States | 2026-10-19 | |
| 21 | A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV NCT07124559 ↗ | RECRUITING | PHASE1 / PHASE2 | National Institute of Allergy and Infectious Diseases (NIAID) | Botswana, Haiti, Kenya, Thailand, Uganda, Zimbabwe | 2026-10-19 | |
| 22 | Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study NCT05960578 ↗ | TERMINATEDResults | PHASE2 | University of Washington | United States | 2026-10-19 | |
| 23 | Erectile and Ejaculatory Function Following Coronary Revascularization NCT07878260 ↗ | COMPLETED | N/A | Saglik Bilimleri Universitesi | Turkey (Türkiye) | 2026-10-19 | |
| 24 | Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial NCT05710328 ↗ | ACTIVE NOT RECRUITING | PHASE2 | ECOG-ACRIN Cancer Research Group | Puerto Rico, United States | 2026-10-19 | |
| 25 | Thyroid Hormone Responses to Repeated Wingate Exercise Versus a Non-Exercising Comparison Group NCT07765290 ↗ | COMPLETED⚠ Results delaymedium +419d | NA | Inonu University | Turkey (Türkiye) | 2026-10-19 | |
| 26 | Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221 ↗ | RECRUITING | PHASE1 / PHASE2 | Revolution Medicines, Inc. | Australia, Austria, Czechia, Denmark, France, Germany, Greece, Italy, Netherlands, South Korea, Spain, Taiwan, United States | 2026-10-19 | |
| 27 | A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size NCT07881809 ↗ | NOT YET RECRUITING | PHASE2 | National Institute of Allergy and Infectious Diseases (NIAID) | United States | 2026-10-19 | |
| 28 | Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected NCT04729387 ↗ | TERMINATEDResults | PHASE3 | Novartis Pharmaceuticals | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, Denmark, Finland, France, Germany, Italy, Malaysia, Mexico, Netherlands, Portugal, Russia, Singapore, Slovakia, South Korea, Spain, Taiwan, Turkey (Türkiye), United Kingdom, United States | 2026-10-19 | |
| 29 | A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer NCT07525206 ↗ | RECRUITING | PHASE3 | AbbVie | Belgium, China, Germany, Greece, Japan, Portugal, South Korea, Spain, Taiwan, United States | 2026-10-19 | |
| 30 | Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology NCT07408375 ↗ | RECRUITING | NA | Nantes University Hospital | France | 2026-10-19 | |
| 31 | Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis NCT06955221 ↗ | RECRUITING | NA | Hospital Universitari de Bellvitge | Spain | 2026-10-19 | |
| 32 | Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study NCT04316117 ↗ | ACTIVE NOT RECRUITING | PHASE2 | ECOG-ACRIN Cancer Research Group | Ireland, Puerto Rico, United States | 2026-10-19 | |
| 33 | Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms NCT07842172 ↗ | NOT YET RECRUITING | PHASE3 | Washington University School of Medicine | United States | 2026-10-19 | |
| 34 | Improving Student Mental Health Through a Universal Trauma-Informed Intervention NCT07842432 ↗ | RECRUITING | NA | Johns Hopkins Bloomberg School of Public Health | United States | 2026-10-19 | |
| 35 | Clinical Genetics Branch Eligibility Screening Survey NCT07005297 ↗ | NOT YET RECRUITING | N/A | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 36 | Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies NCT06948097 ↗ | RECRUITING | PHASE1 | National Heart, Lung, and Blood Institute (NHLBI) | United States | 2026-10-19 | |
| 37 | Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene NCT06052631 ↗ | NOT YET RECRUITING | N/A | National Center for Complementary and Integrative Health (NCCIH) | United States | 2026-10-19 | |
| 38 | Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001 NCT07867288 ↗ | RECRUITING | PHASE1 | Haya Therapeutics, Inc. | United States | 2026-10-19 | |
| 39 | Screening Protocol NCT07712874 ↗ | NOT YET RECRUITING | N/A | National Center for Complementary and Integrative Health (NCCIH) | United States | 2026-10-19 | |
| 40 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) NCT04267848 ↗ | RECRUITING⚠ Results delaymedium | PHASE3 | National Cancer Institute (NCI) | Guam, United States | 2026-10-19 | |
| 41 | Preoperative Airway Assessment and Difficult Tracheal Intubation NCT07881107 ↗ | COMPLETED | N/A | Bursa City Hospital | Turkey (Türkiye) | 2026-10-19 | |
| 42 | Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer NCT05642195 ↗ | SUSPENDED | PHASE1 / PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 43 | Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women NCT06197568 ↗ | RECRUITING | PHASE2 | Azure Biotech Inc. | United States | 2026-10-19 | |
| 44 | Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers NCT07089797 ↗ | COMPLETED | NA | The University of Hong Kong | China | 2026-10-19 | |
| 45 | Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs NCT07161635 ↗ | COMPLETED | NA | Alcon Research | United States | 2026-10-19 | |
| 46 | Protein Signature Based Screening of Colorectal Adenomas and Cancer NCT07881549 ↗ | ENROLLING BY INVITATION | N/A | Region Skane | Sweden | 2026-10-19 | |
| 47 | A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) NCT07060807 ↗ | RECRUITING | PHASE3 | Merck Sharp & Dohme LLC | Argentina, Australia, Brazil, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Mexico, Peru, Poland, South Korea, Spain, Taiwan, Thailand, Turkey (Türkiye), United Kingdom, United States, Vietnam | 2026-10-19 | |
| 48 | Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients NCT07631650 ↗ | RECRUITING | PHASE2 | Matthew Spector | United States | 2026-10-19 | |
| 49 | Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia NCT06317662 ↗ | RECRUITING | PHASE2 | National Cancer Institute (NCI) | Puerto Rico, United States | 2026-10-19 | |
| 50 | Changes in Energy Expenditure in Response to Physical Activity in Healthy Adults NCT07529132 ↗ | RECRUITING | N/A | Medical University of Bialystok | Poland | 2026-10-19 | |
| 51 | Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies NCT06904066 ↗ | RECRUITING | PHASE1 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 52 | Addictions Neuroclinical Assessment (ANA) NCT04946851 ↗ | ENROLLING BY INVITATION | N/A | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | United States | 2026-10-19 | |
| 53 | Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART) NCT06280820 ↗ | ENROLLING BY INVITATION | N/A | National Heart, Lung, and Blood Institute (NHLBI) | United States | 2026-10-19 | |
| 54 | Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases NCT07619534 ↗ | RECRUITING | N/A | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 55 | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas NCT02523014 ↗ | RECRUITING | PHASE2 | Alliance for Clinical Trials in Oncology | United States | 2026-10-19 | |
| 56 | A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity NCT06406465 ↗ | RECRUITING | PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 57 | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis NCT07071519 ↗ | RECRUITING | PHASE3 | AbbVie | Belgium, Brazil, Canada, China, Germany, Greece, Italy, Japan, Poland, Serbia, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States | 2026-10-19 | |
| 58 | Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities NCT07752979 ↗ | RECRUITING | PHASE2 | AbbVie | Puerto Rico, United States | 2026-10-19 | |
| 59 | Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators NCT07133880 ↗ | RECRUITING | PHASE4 | University of Tennessee Graduate School of Medicine | United States | 2026-10-19 | |
| 60 | Wastewater Epidemiology to Document the Circulation of Influenza Viruses NCT07880834 ↗ | NOT YET RECRUITING | N/A | Central Hospital, Nancy, France | — | 2026-10-19 | |
| 61 | Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas NCT03984448 ↗ | ACTIVE NOT RECRUITING | PHASE2 / PHASE3 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 62 | Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease NCT07661056 ↗ | RECRUITING | PHASE3 | Biohaven Therapeutics Ltd. | Canada, Puerto Rico, United States | 2026-10-19 | |
| 63 | Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment NCT06589804 ↗ | RECRUITING | PHASE3 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 64 | Effect of Sensorimotor Training on Pain and Gait Performance in Patients With Discogenic Sciatica NCT07805265 ↗ | RECRUITING | NA | Cairo University | Egypt | 2026-10-19 | |
| 65 | Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery NCT07420712 ↗ | COMPLETED | NA | Kartal Kosuyolu High Speciality Training and Research Hospital | Turkey (Türkiye) | 2026-10-19 | |
| 66 | Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease NCT07619547 ↗ | RECRUITING | N/A | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | United States | 2026-10-19 | |
| 67 | Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism NCT06690294 ↗ | NOT YET RECRUITING | N/A | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | United States | 2026-10-19 | |
| 68 | Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors NCT04665739 ↗ | RECRUITING | PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 69 | Modeling Host-Pathogen Interaction Using Lymphoid Organoids NCT06479837 ↗ | RECRUITING | N/A | National Institute of Allergy and Infectious Diseases (NIAID) | United States | 2026-10-19 | |
| 70 | Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer NCT06058377 ↗ | RECRUITING | PHASE3 | National Cancer Institute (NCI) | Puerto Rico, United States | 2026-10-19 | |
| 71 | A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) NCT07513376 ↗ | RECRUITING | PHASE3 | Merck Sharp & Dohme LLC | Australia, Brazil, Canada, Chile, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, Poland, South Korea, Spain, Taiwan, Turkey (Türkiye), United Kingdom, United States | 2026-10-19 | |
| 72 | Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders NCT07683104 ↗ | RECRUITING | N/A | National Institute of Allergy and Infectious Diseases (NIAID) | United States | 2026-10-19 | |
| 73 | Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) NCT07756840 ↗ | NOT YET RECRUITING | PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 74 | Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms NCT06303193 ↗ | RECRUITING | PHASE1 / PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 75 | PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) NCT07169630 ↗ | RECRUITING | PHASE1 | National Institute of Mental Health (NIMH) | United States | 2026-10-19 | |
| 76 | Pulmonary Hypertension (PH) Biorepository for Translational Research NCT07647549 ↗ | NOT YET RECRUITING | N/A | National Institutes of Health Clinical Center (CC) | United States | 2026-10-19 | |
| 77 | 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations NCT05588141 ↗ | RECRUITING | PHASE1 / PHASE2 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 78 | Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder NCT07772401 ↗ | RECRUITING | NA | Second Affiliated Hospital, Zhejiang University, School of Medicine | China | 2026-10-19 | |
| 79 | Normal Values in Hearing and Balance Testing NCT01629108 ↗ | RECRUITING | N/A | National Institute on Deafness and Other Communication Disorders (NIDCD) | United States | 2026-10-19 | |
| 80 | Neuro-MoD: Neuroplasticity With Motor Development NCT07738432 ↗ | RECRUITING | NA | University of Wisconsin, Madison | United States | 2026-10-19 | |
| 81 | Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma NCT06487481 ↗ | RECRUITING | PHASE1 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 82 | Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial NCT06498635 ↗ | RECRUITING | PHASE3 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 83 | Prophylactic Reinforcement of Ventral Abdominal Incisions Trial NCT03911700 ↗ | ACTIVE NOT RECRUITING | NA | C. R. Bard | Austria, Belgium, France, Germany, United States | 2026-10-19 | |
| 84 | A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke NCT07754825 ↗ | NOT YET RECRUITING | PHASE2 | Shanghai Pharmaceuticals Holding Co., Ltd | China | 2026-10-19 | |
| 85 | Adrenal Function in Critical Illness NCT00156767 ↗ | COMPLETED | N/A | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | United States | 2026-10-19 | |
| 86 | Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency NCT06948214 ↗ | RECRUITING | PHASE3 | Lumos Pharma | Argentina, Australia, Chile, India, New Zealand, Thailand, United Kingdom, United States | 2026-10-19 | |
| 87 | Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID) NCT03738774 ↗ | ACTIVE NOT RECRUITING | N/A | Vanderbilt University Medical Center | United States | 2026-10-19 | |
| 88 | Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis NCT06192160 ↗ | RECRUITING | PHASE2 | National Institute of Allergy and Infectious Diseases (NIAID) | Botswana, Brazil, Haiti, India, Kenya, Malawi, Mexico, Peru, Philippines, South Africa, Thailand, Uganda, Vietnam, Zimbabwe | 2026-10-19 | |
| 89 | Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) NCT01306019 ↗ | RECRUITING | PHASE1 / PHASE2 | National Institute of Allergy and Infectious Diseases (NIAID) | United States | 2026-10-19 | |
| 90 | TMS + Exposure Therapy for Pediatric OCD: Second Phase NCT07859683 ↗ | RECRUITING | NA | Bradley Hospital | United States | 2026-10-19 | |
| 91 | An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis NCT07879885 ↗ | RECRUITING | PHASE2 | Hansoh BioMedical R&D Company | China | 2026-10-19 | |
| 92 | Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease NCT07509034 ↗ | RECRUITING | PHASE1 | National Cancer Institute (NCI) | United States | 2026-10-19 | |
| 93 | Human Experimental Models of Pain (HEMP) NCT07549490 ↗ | NOT YET RECRUITING | NA | National Center for Complementary and Integrative Health (NCCIH) | United States | 2026-10-19 | |
| 94 | Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis NCT07876648 ↗ | RECRUITING | NA | Universitaire Ziekenhuizen KU Leuven | Belgium | 2026-10-19 | |
| 95 | Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) NCT06868914 ↗ | NOT YET RECRUITING | PHASE1 | National Institute on Drug Abuse (NIDA) | United States | 2026-10-19 | |
| 96 | Longitudinal Natural History Protocol for PRKN- and PINK1-Linked PD NCT07613112 ↗ | NOT YET RECRUITING | N/A | National Institute of Neurological Disorders and Stroke (NINDS) | United States | 2026-10-19 | |
| 97 | Effects of Meal Macronutrients on Postprandial Lipids NCT07313787 ↗ | NOT YET RECRUITING | PHASE2 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | United States | 2026-10-19 | |
| 98 | A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists NCT07789106 ↗ | RECRUITING | NA | StudySetGo | United Kingdom | 2026-10-19 | |
| 99 | FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) NCT07111065 ↗ | RECRUITING | PHASE2 | National Institute of Environmental Health Sciences (NIEHS) | United States | 2026-10-19 | |
| 100 | Intraoperative OCT Guidance of Intraocular Surgery II NCT03713268 ↗ | RECRUITING | N/A | Duke University | United States | 2026-10-19 |